In clinical trials, donanemab (Kisunla) modestly slowed the pace of thinking declines among patients in the early stages of the memory-robbing disease. But it also carried significant safety risks, including...
FDA advisers support new Alzheimer’s drug
Jun 11, 2024
A US Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the benefits of a new drug for Alzheimer’s outweigh its harms, which can include brain swelling and...
4.0 percent of seniors had received dementia diagnosis in 2022
Jun 13, 2024
An increase in the percentage with a dementia diagnosis was seen with increasing age; a decrease was seen with an increasing education level.
The 5-Cog paradigm improves diagnosis, management of dementia
Jun 11, 2024
A threefold improvement was seen in dementia care actions with the 5-Cog paradigm, a culturally adept cognitive detection tool.
Odds of death lower with surgery for hip fracture in patients with dementia
Jun 03, 2024
A reduced odds of 180-day mortality was seen for patients with moderate to severe or mild dementia treated surgically.
American Academy of Neurology, April 13-18
Apr 23, 2024
The annual meeting of the American Academy of Neurology was held this year from April 13 to 18 in Denver, drawing participants from around the world, including clinicians, academicians, allied health professionals,...
Minorities with dementia show lower incidence of amyloid PET positivity
Oct 12, 2022
The authors say that the findings have implications for treating dementia unrelated to amyloid plaques.
US surgeon general announces national plan to fight ‘loneliness epidemic’
May 02, 2023
Loneliness can lead to pain, depression and shorter life spans in older adults and can impact sleep, inflammation and the immune system in younger adults.
FDA OKs marketing of new test to help diagnose Alzheimer disease
May 06, 2022
The test is indicated for patients 55 years and older who present with cognitive impairment and are being evaluated for Alzheimer’s disease and cognitive decline.
AAN: Higher scores on life’s simple 7 linked to lower dementia risk in women
Mar 01, 2023
For women, a higher AHA Life’s Simple 7 score at baseline in midlife is linked to a reduced risk for later-life dementia.